<DOC>
	<DOC>NCT01876251</DOC>
	<brief_summary>This study is aimed to determine the tolerability of the PF-03084014 plus docetaxel combination in patients with advanced breast cancer. Preliminary information about the efficacy of the combination will also be collected.</brief_summary>
	<brief_title>A Study Evaluating The PF-03084014 In Combination With Docetaxel In Patients With Advanced Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<criteria>Diagnosis of breast cancer with evidence of a) metastatic or b) locally recurrent/advanced disease. Prior treatment with a gamma secretase inhibitors or other Notch signaling inhibitors.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Breast cancer metastatic</keyword>
	<keyword>docetaxel</keyword>
	<keyword>PF-03084014</keyword>
</DOC>